Meeting
2024 ASCO Annual Meeting
High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study.
Authors
Huiyan Luo
Sun Yat Sen University Cancer Center, Laboratory of Oncology in South China, Guangzhou, China
Huiyan Luo , Pansong Li , Wei Wei , Yong-Bin Lin , Hong Yang , Han Yang , Kong-Jia Luo , Xiaoman Hu , Haibo Qiu , Shu-Qiang Yuan , Yuan-fang Li , Xiao-Jun Lin , Bo-kang Cui , Li Xu , Rong-Xin Zhang , Wenhua Fan , Chunyan Lan , Ting Wan , Qi-hua Zhang , Rui-Hua Xu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 3043)
DOI
10.1200/JCO.2024.42.16_suppl.3043
Abstract #
3043
Poster Bd #
188
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization.
First Author: Le Son Tran
Poster
2011 ASCO Annual Meeting
A novel plasma amino acid profile-based biomarker for early detection of ovarian cancer.
First Author: E. Miyagi
Poster
2024 ASCO Annual Meeting
Evaluating the potential of micronuclei DNA from erythrocytes for early detection or recurrence risk prediction of colorectal cancer.
First Author: Xingyun Yao
Poster
2024 ASCO Annual Meeting
Real-world ctDNA testing patterns, associated biomarkers and sites of metastasis in early stage colorectal cancer.
First Author: Erin Fidyk